Axa S.A. Vanda Pharmaceuticals Inc. Transaction History

Axa S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $604,336 - $927,684	141,200 New	141,200 $609,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $160,132 - $203,648	-17,200 Closed	0 $0
Q1 2022 Feb 14, 2023	BUY	$10.84 - $16.55 $186,448 - $284,660	17,200 New	17,200 $194,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $186,448 - $284,660	17,200 New	17,200 $195,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $374,991 - $505,246	-23,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $36,840 - $51,048	-2,400 Reduced 9.13%	23,900 $410,000
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $413,173 - $565,713	26,300 New	26,300 $566,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.